Bloomberg Intelligence cover image

BI Weekend: Nvidia Earnings, Paramount Saga

Bloomberg Intelligence

00:00

Eli Lilly's Strategic Shift and Port Dynamics

This chapter examines Eli Lilly's decision to discount its drug ZEPBOUND to address supply shortages and enhance patient access while navigating market competition. It also explores the rise in cargo imports at the Port of Los Angeles, the challenges faced in the shipping industry, and the implications of federal investment in port infrastructure. Additionally, the discussion touches on geopolitical impacts on trade and shifts in reliance from Chinese to Southeast Asian goods.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app